Most stem cell clinics today offer mesenchymal stem cells (MSCs), which function primarily as medicinal signaling cells. They reduce inflammation but don’t actually regenerate new tissue. While helpful for temporary relief, this often leads to a misunderstanding many patients believe they’re receiving regenerative treatments when they’re really getting anti-inflammatory therapy. On the other hand, clinics offering embryonic or fetal stem cells (or even induced pluripotent stem cells, iPSCs) aim